Brief: Surmodics Q4 EPS USD 0.47
08/11/2023 12:30
Nov 08 (Reuters) - Surmodics Q4 pretax profit USD -2.789 million. * Q4 product sales USD 15.363 million * Q4 basic EPS USD 0.48 * Q4 net income USD 6.694 million * outlook FY revenue USD 116-121 million * outlook FY revenue growth 9-14%
Recent news on SurModics
See all newsU.S. STOCKS ON THE MOVE-Surmodics, Cheniere Energy, American Public Education
U.S. STOCKS ON THE MOVE-Surmodics, Energy stocks, American Public Education
Surmodics jumps after US judge rejects FTC's bid to block acquisition by GTCR
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions